Cipla strengthens on transferring its consumer healthcare business to Cipla Health

02 Mar 2016 Evaluate

Cipla is currently trading at Rs. 522.00, up by 4.50 points or 0.87% from its previous closing of Rs. 517.50 on the BSE.

The scrip opened at Rs. 524.00 and has touched a high and low of Rs. 525.75 and Rs. 520.00 respectively. So far 20028 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 752.45 on 10-Mar-2015 and a 52 week low of Rs. 505.55 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs. 528.75 and Rs. 505.55 respectively. The current market cap of the company is Rs. 41574.62 crore.

The promoters holding in the company stood at 37.57%, while Institutions and Non-Institutions held 35.53% and 26.89% respectively.

Cipla has transferred its consumer healthcare business to Cipla Health, subsidiary of the company with effect from February 29, 2016.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.


Cipla Share Price

1507.40 10.45 (0.70%)
18-Dec-2025 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.20
Dr. Reddys Lab 1278.20
Cipla 1507.40
Zydus Lifesciences 916.75
Lupin 2124.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×